Literature DB >> 7531367

Modulation of chemotropism in the developing spinal cord by substance P.

C De Felipe1, R D Pinnock, S P Hunt.   

Abstract

Developing axons find their targets through direct contact with cues in the extracellular environment and in response to gradients of diffusible factors. The floor plate, a neuroepithelial structure, guides developing commissural axons in the spinal cord by release of chemoattractants. Floor plate cells express neurokinin-1 receptors, and a transiently appearing subpopulation of commissural axons contains substance P, the neuropeptide ligand for this receptor. Substance P increases the amount of axon outgrowth from dorsal horn explants cocultured with floor plate explants. Results of experiments with embryonic rats suggest that substance P released from pioneering neuronal pathways may regulate the release of chemoattractants from floor plate cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531367     DOI: 10.1126/science.7531367

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Spatiotemporal characteristics of the neural activities processing consonant/dissonant tones in melody.

Authors:  Shinya Kuriki; Naoko Isahai; Asuka Ohtsuka
Journal:  Exp Brain Res       Date:  2004-12-02       Impact factor: 1.972

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene.

Authors:  A Zimmer; A M Zimmer; J Baffi; T Usdin; K Reynolds; M König; M Palkovits; E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.

Authors:  Leonardo Lorente; María M Martín; Teresa Almeida; Mariano Hernández; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; Alejandro Jiménez
Journal:  Crit Care       Date:  2015-04-27       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.